We fed WT and CD1d-/- mice either an FFD or MCD diet to evaluate whether NKT cells modulate NASH-related fibrosis and whether chronic administration of α-GalCer, an NKT cell activator, has an effect on liver fibrogenesis. The gene discussed is CD1D; the disease is metabolic dysfunction-associated steatohepatitis.